Accelerated stable cell line development from 20-24 weeks to 10 weeks, saving 3 months on clinical trial timeline.
A mid-sized pharmaceutical company developing antibody therapeutics for oncology. Their lead candidate was in late preclinical development with a tight clinical trial timeline.
Traditional stable cell line development would take 20-24 weeks, potentially delaying their clinical trial start and missing competitive windows.
Our AI platform can accelerate your antibody development timeline while maintaining quality.
Discuss Your Timeline